Sign in
4

Changes in Ownership

CERUS CORP Filed Acc 0001209191-22-019064

Chief Scientific Officer sold 30,307 shares at $5.04 ($152,735)

  • Chief Scientific Officer acquired 84,437 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
CORASH LAURENCE M Chief Scientific Officer 2022-03-12 Option exercise +45,000 2,117,586 D: show line 1 in the form
CORASH LAURENCE M Chief Scientific Officer 2022-03-14 Sale −16,152 $5.04 $81,400 2,101,434 D: show line 2 in the form
CORASH LAURENCE M Chief Scientific Officer 2022-03-12 Option exercise +22,770 2,124,204 D: show line 3 in the form
CORASH LAURENCE M Chief Scientific Officer 2022-03-14 Sale −8,173 $5.04 $41,189 2,116,031 D: show line 4 in the form
CORASH LAURENCE M Chief Scientific Officer 2022-03-12 Option exercise +16,667 2,132,698 D: show line 5 in the form
CORASH LAURENCE M Chief Scientific Officer 2022-03-14 Sale −5,982 $5.04 $30,147 2,126,716 D: show line 6 in the form
Open-market sales · 30,307 sh · avg $5.04 · $152,735

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
CORASH LAURENCE M Chief Scientific Officer 2022-03-12 Option exercise · Restricted Stock Unit −45,000 0 D: show line 7 in the form
CORASH LAURENCE M Chief Scientific Officer 2022-03-12 Option exercise · Restricted Stock Unit −22,770 23,460 D: show line 8 in the form
CORASH LAURENCE M Chief Scientific Officer 2022-03-12 Option exercise · Restricted Stock Unit −16,667 33,333 D: show line 9 in the form
Loading xslF345X03/doc4.xml…